Gapping up
In reaction to strong earnings/guidance:
In reaction to strong earnings/guidance:
- TOPS +61.3%, RGSE +22%, (also completes offerings that raised total net proceeds of $16.0 million; regains Nasdaq compliance and now debt-free)
- TRUE +14.7%, AIRG +11.1%, COHU +11.1%, ANET +10.8%, TMST +10%, RWLK +8.7%, CYTK +7.1%, CGNX +5%, DE +3.7%
- TTD +3.6%, (also files registration statement for proposed follow-on offering by selling shareholders), IMGN +3.2%, GOL +3.2%,KEYS +3.1%
- WBMD +2.9%, (also commenced a process to explore and evaluate potential strategic alternatives ), RUTH +2.8%, CTB +2.1%, DVA +1%
- AUY +0.9%, DLR +0.9%, FIVN +0.8%
M&A news:
- LMIA +49.6% (to be acquired by Sonaca Group for $14.00 per share)
- UL +10.5% (Kraft Heinz (KHC) confirms that it made proposal to Unilever about combining the two groups), UN +9.4%, KHC +5.1%
- ZPIN +3.5% (Zhaopin special committee is in advanced discussions regarding a potential transaction after receiving preliminary non-binding proposal $18.00 in cash per ADS)
Other news:
- HTBX +5.3% (presents data from its Phase 2 trial evaluating vesigenurtacel-L)
- AZN +1.7% (reports Phase III trial for Lynparza meets primary endpoint), LC +1.2% (modest rebound following yesterday's 8% decline)
- ARAY +0.9% (presents data from a Phase II study which showed that treatment with the CyberKnife System for low- and intermediate-risk prostate cancer provides 'excellent long-term results' at ASCOGU )
- CNHI +0.9% (in sympathy with DE results)
- ABBV +0.7% (authorizes a $5 bln increase to AbbVie's existing stock repurchase program)
Analyst comments:
- CC +1.4% (upgraded to Positive from Neutral at Susquehanna)
- TPX +0.9% (upgraded to Outperform at Raymond James)